Medical Equipment Manufacturer Secures Rs 264.33 Crore Order from Central Medical Service Society (CMSS)

Kiran DSIJCategories: Multibaggers, Trending

Medical Equipment Manufacturer Secures Rs 264.33 Crore Order from Central Medical Service Society (CMSS)

From Rs 88.15 (52-week low) to Rs 323 per share, the stock has given multibagger returns of 266 per cent.

Hemant Surgical Industries Limited has secured a significant domestic contract from the Central Medical Service Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. Valued at Rs 264.33 crore (inclusive of all Taxes and duties), the order entails the supply of advanced medical imaging equipment, specifically Flat Panel Detectors—complete with batteries and routers—alongside X-ray generators and hard travel cases. While the final commercial terms and specific delivery schedules are still being finalised through ongoing discussions, the company has agreed to begin interim supplies immediately, citing the project's national importance and a direct request from the CMSS.

The execution of this substantial order is expected to be carried out in tranches, with a target completion date of September 30, 2026. This timeline remains subject to further negotiations and potential extensions requested by Hemant Surgical Industries to the CMSS. This contract represents a major undertaking for the entity within the domestic healthcare infrastructure space, focusing on the distribution of critical diagnostic utilities across the country.

Hunt for the next peak performer! DSIJ's multibagger Pick identifies high-risk, high-reward stocks with potential to triple BSE 500 returns in 3–5 years. Download Service Note

About the Company

Founded in 1989, Hemant Surgical Industries Ltd (HSIL) is a versatile player in the medical technology sector, specialising in the manufacturing, importing, and marketing of critical healthcare equipment and disposables. The company maintains a strong focus on renal care, providing everything from new dialysis machines and haemodialysis solutions to the expert refurbishment of second-hand units. Beyond nephrology, HSIL is a certified provider of essential medical devices such as oxygen concentrators, ultrasound machines, and digital thermometers, while also designing its own line of nebulisers under the AERO brand.

The company has a market cap of over Rs 400 crore and has delivered good profit growth of 74.1 per cent CAGR over the last 5 years. From Rs 88.15 (52-week low) to Rs 323 per share, the stock has given multibagger returns of 266 per cent.

Add DSIJ as your preferred news source on Google

Add Now

Disclaimer: The article is for informational purposes only and not investment advice.